A pensioner has claimed she was left distressed after an experience at Manchester Airport that she says made her feel ...

Algorithms in clinical decision tools have been making it harder for certain racial and socioeconomic groups to receive the healthcare they deserve.

Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...

Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for ...

In the swiftly evolving field of artificial intelligence (AI), the technology's capability to revolutionize care processes in ...

Shares of Cyclerion Therapeutics climbed after the company entered an agreement to integrate Medsteer's technology into its lead program in development for treatment-resistant depression. The stock ...

When Amanda Smith walked into the kitchen one night in 2015 to warm up a bottle for her four-month-old daughter, she couldn’t make out the numbers on the microwave. They were blurry. They’d never been ...

Supported by an unrestricted grant from INCYTE. In this webinar Julie Ann Lough is joined by three experts in the fields of oncology and pathology: Albrecht Stenzinger, Nicola Normanno and Angela ...

Artificial intelligence is stepping into the fight against cancer — and, according to Fox News senior medical analyst Dr. Marc Siegel, it could be a game-changer. On the Monday episode of "Fox & ...

For decades, we trusted big pharmaceutical companies to deliver the cures of the future—blockbuster drugs, cutting-edge therapies, vaccines that changed history, and lives saved. But that model is ...

The evolving treatment landscape for unfit patients with newly diagnosed acute myeloid leukemia (AML) centers on venetoclax combination and personalized strategies. Management of newly diagnosed acute ...

Curative-intent multimodality treatment—combining local treatments such as surgery or radiotherapy with systemic therapy—is the cornerstone of care in stage II–III non-small cell lung cancer (NSCLC).